Procept Biorobotics Corp (PRCT) - Total Liabilities
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) has total liabilities worth $131.26 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Procept Biorobotics Corp operating cash flow efficiency to assess how effectively this company generates cash.
Procept Biorobotics Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's total liabilities have evolved over time, based on quarterly financial data. See Procept Biorobotics Corp shareholders equity for net asset value and shareholders' equity analysis.
Procept Biorobotics Corp Competitors by Total Liabilities
The table below lists competitors of Procept Biorobotics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cogeco Communications Inc
TO:CCA
|
Canada | CA$6.04 Billion |
|
Nextdecade Corp
NASDAQ:NEXT
|
USA | $8.03 Billion |
|
Kinnevik Investment AB ser. B
ST:KINV-B
|
Sweden | Skr2.25 Billion |
|
VIA Technologies Inc
TW:2388
|
Taiwan | NT$13.15 Billion |
|
Atalaya Mining Ltd
F:E5S1
|
Germany | €178.66 Million |
|
Cheil Worldwide
KO:030000
|
Korea | ₩1.95 Trillion |
|
Chongqing Department Store Co Ltd
SHG:600729
|
China | CN¥11.41 Billion |
|
NÜRNBERGER Beteiligungs-AG
F:NBG6
|
Germany | €35.73 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Procept Biorobotics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Procept Biorobotics Corp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Procept Biorobotics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Procept Biorobotics Corp (2019–2024)
The table below shows the annual total liabilities of Procept Biorobotics Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $131.80 Million | +6.32% |
| 2023-12-31 | $123.97 Million | +10.43% |
| 2022-12-31 | $112.26 Million | +60.52% |
| 2021-12-31 | $69.93 Million | +7.57% |
| 2020-12-31 | $65.01 Million | +98.42% |
| 2019-12-31 | $32.76 Million | -- |
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more